Erin N. Newburn, MS, PhD

Company: Personalis, Inc.

Job title: Sr. Director, Field Applications Scientist

Seminars:

NeXT Personal: NextGen MRD Testing for Solid Tumors 12:45 pm

The ability to monitor and predict molecular recurrence at the earliest time points during or after curative therapy in patients previously diagnosed with cancer may inform precision treatment regimens or spare patients from costly side effects. Here we discuss NeXT Personal, an advanced next-generation MRD platform optimized for sensitivity.Read more

day: Day Two